XML 27 R12.htm IDEA: XBRL DOCUMENT

Other Balance Sheet Details

12 Months Ended

Dec. 31, 2020

Other Balance Sheet Details [Abstract]

Inventories consisted of the following:


	December 31,
(in millions)	2020		2019
Raw materials	$	16.6	$	14.1
Work in process	2.4		1.5
Finished goods	9.0		1.7
Total inventories	$	28.0	$	17.3

Property and equipment, net, consisted of the following:


	December 31,
(in millions)	2020		2019
Tenant improvements	$	29.5	$	26.3
Scientific equipment	39.2		33.5
Computer equipment	13.9		12.5
Furniture and fixtures	3.7		3.2
	86.3		75.5
Less accumulated depreciation	(41.7)		(33.6)
Total property and equipment, net	$	44.6	$	41.9

Accounts payable and accrued liabilities consisted of the following:


	December 31,
(in millions)	2020		2019
Accrued employee related costs	$	38.2	$	38.9
Revenue-related reserves for discounts and allowances	34.6		30.6
Accrued development costs	32.9		25.5
Accrued Branded Prescription Drug Fee	23.6		4.9
Accounts payable and other accrued liabilities	39.4		41.4
Total accounts payable and accrued liabilities	$	168.7	$	141.3

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.


	December 31,
(in millions)	2020		2019
Cash and cash equivalents	$	187.1	$	112.3
Restricted cash	3.2		3.2
Total cash, cash equivalents and restricted cash	$	190.3	$	115.5